{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:32:50Z","timestamp":1792481570140,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.7759\/cureus.83328","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:51:03Z","timestamp":1746186663000},"source":"Crossref","is-referenced-by-count":3,"title":["Current Epidemiological and Clinical Features of Sarcoidosis in Japan: A Nationwide Claims Data Study"],"prefix":"10.7759","author":[{"given":"Koichi","family":"Miyashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi MC","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007, 357:2153-65. 10.1056\/NEJMra071714","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-105569","article-title":"Epidemiology and clinical presentation of sarcoidosis (Article in German)","volume":"234","author":"Costabel U","year":"2017","unstructured":"Costabel U, Wessendorf TE, Bonella F. Epidemiology and clinical presentation of sarcoidosis (Article in German). Klin Monbl Augenheilkd. 2017, 234:790-5. 10.1055\/s-0042-105569","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre D","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014, 383:1155-67. 10.1016\/S0140-6736(13)60680-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman RP","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, et al.. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001, 164:1885-9. 10.1164\/ajrccm.164.10.2104046","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman RP","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003, 361:1111-8. 10.1016\/S0140-6736(03)12888-7","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson MA","year":"2015","unstructured":"Judson MA. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol. 2015, 49:63-78. 10.1007\/s12016-014-8450-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman RP","year":"2013","unstructured":"Baughman RP, Nunes H, Sweiss NJ, Lower EE. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J. 2013, 41:1424-38. 10.1183\/09031936.00060612","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl038","article-title":"Presenting characteristics as predictors of duration of treatment in sarcoidosis","volume":"99","author":"Baughman RP","year":"2006","unstructured":"Baughman RP, Judson MA, Teirstein A, Yeager H, Rossman M, Knatterud GL, Thompson B. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM. 2006, 99:307-15. 10.1093\/qjmed\/hcl038","journal-title":"QJM"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman RP","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, et al.. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016, 13:1244-52. 10.1513\/AnnalsATS.201511-760OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002461","article-title":"National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022","volume":"11","author":"Salonen J","year":"2024","unstructured":"Salonen J, Kaarteenaho R. National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022. BMJ Open Respir Res. 2024, 11:10.1136\/bmjresp-2024-002461","journal-title":"BMJ Open Respir Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00444-2019","article-title":"Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study","volume":"54","author":"Fidler LM","year":"2019","unstructured":"Fidler LM, Balter M, Fisher JH, To T, Stanbrook MB, Gershon A. Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study. Eur Respir J. 2019, 54:10.1183\/13993003.00444-2019","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema EV","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016, 48:1690-9. 10.1183\/13993003.00477-2016","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto T","year":"2008","unstructured":"Morimoto T, Azuma A, Abe S, et al.. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008, 31:372-9. 10.1183\/09031936.00075307","journal-title":"Eur Respir J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27554-3","article-title":"Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan","volume":"8","author":"Hattori T","year":"2018","unstructured":"Hattori T, Konno S, Shijubo N, et al.. Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan. Sci Rep. 2018, 8:9440. 10.1038\/s41598-018-27554-3","journal-title":"Sci Rep"},{"key":"ref15","article-title":"ICD-10: International Statistical Classification of Diseases and Related Health Problems, tenth revision, 2nd ed","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems, tenth revision, 2nd ed. World Health Organization, 2004."},{"key":"ref16","unstructured":"Act on medical care for patients with intractable diseases (Act no. 50 of 2014). (2014). Accessed. November 15, 2024: https:\/\/www.japaneselawtranslation.go.jp\/ja\/laws\/view\/3363\/en."},{"key":"ref17","unstructured":"European Pharmaceutical Market Research Association (EphMRA). Anatomical classification. (2022). Accessed: November 15, 2024: https:\/\/www.ephmra.org\/anatomical-classification."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18916\/9784771905832","article-title":"Practical Guide for the Diagnosis and Treatment of Sarcoidosis 2023 (In Japanese)","year":"2023","unstructured":"Practical Guide for the Diagnosis and Treatment of Sarcoidosis 2023 (In Japanese). Japan Society of Sarcoidosis and Other Granulomatous Disorders (ed). Katsuseido Publishing, Tokyo; 2023. 10.18916\/9784771905832"},{"key":"ref19","article-title":"ACTH, adrenal steroids, and pharmacology of the adrenal cortex","author":"Schimmer BP","year":"2011","unstructured":"Schimmer BP, Funder JW. ACTH, adrenal steroids, and pharmacology of the adrenal cortex. Goodman and Gilman\u2019s: The Pharmacological Basis of Therapeutics. Brunton LL, Chabner BA, Knollmann BC (ed): McGraw-Hill, New York; 2011. 1209-35."},{"key":"ref20","unstructured":"Current population estimates as of October 1, 2022. (2022). Accessed. November 15, 2024: https:\/\/www.stat.go.jp\/english\/data\/jinsui\/2022np\/index.html."},{"key":"ref21","unstructured":"The R Project for Statistical Computing. (2024). Accessed. November 15, 2024: https:\/\/www.R-project.org\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol EI","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al.. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015, 12:e1001885. 10.1371\/journal.pmed.1001885","journal-title":"PLoS Med"},{"key":"ref23","unstructured":"Ethical guidelines for medical and health research involving human subjects (In Japanese). (2024). Accessed. November 15, 2024: https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka\/0000153339.pdf."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","year":"2021","unstructured":"2. Classification and diagnosis of diabetes. standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S15-33. 10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"key":"ref25","article-title":"Epidemiological survey on sarcoidosis in Japan (Article in Japanese)","volume":"22","author":"Arai T","year":"1968","unstructured":"Arai T. Epidemiological survey on sarcoidosis in Japan (Article in Japanese). Iryo. 1968, 22:605-12.","journal-title":"Iryo"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v36i2.7206","article-title":"A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population","volume":"36","author":"Low D","year":"2019","unstructured":"Low D, Simpson KN, Rissmiller R, James E. A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population. Sarcoidosis Vasc Diffuse Lung Dis. 2019, 36:124-9. 10.36141\/svdld.v36i2.7206","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref27","article-title":"Trends in the epidemiology of patients with diabetes in Japan","volume":"53","author":"Morimoto A","year":"2010","unstructured":"Morimoto A. Trends in the epidemiology of patients with diabetes in Japan. Jpn Med Assoc J. 2010, 53:36-40.","journal-title":"Jpn Med Assoc J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2188\/jea.10.79","article-title":"Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population","volume":"10","author":"Doi Y","year":"2000","unstructured":"Doi Y, Minowa M, Okawa M, Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J Epidemiol. 2000, 10:79-86. 10.2188\/jea.10.79","journal-title":"J Epidemiol"},{"key":"ref29","article-title":"Incidence of clinical vertebral fractures and the rate for operation of the elderly in Kure City; large-scale claim database analysis (Article in Japanese)","volume":"11","author":"Hamasaki T","year":"2020","unstructured":"Hamasaki T, Okimoto N, Teramoto H, et al.. Incidence of clinical vertebral fractures and the rate for operation of the elderly in Kure City; large-scale claim database analysis (Article in Japanese). J Spine Res. 2020, 11:1374-9.","journal-title":"J Spine Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx007","article-title":"Herpes zoster and recurrent herpes zoster","volume":"4","author":"Shiraki K","year":"2017","unstructured":"Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017, 4:ofx007. 10.1093\/ofid\/ofx007","journal-title":"Open Forum Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.854059","article-title":"Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)","volume":"24","author":"Yamanaka H","year":"2014","unstructured":"Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014, 24:33-40. 10.3109\/14397595.2013.854059","journal-title":"Mod Rheumatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkad030","article-title":"Autoimmune comorbidities associated with sarcoidosis: a case-control study in the All of Us research program","volume":"7","author":"Murphy MJ","year":"2023","unstructured":"Murphy MJ, Edemobi P, Leasure AC, Gulati M, Miller EJ, Damsky W, Cohen JM. Autoimmune comorbidities associated with sarcoidosis: a case-control study in the All of Us research program. Rheumatol Adv Pract. 2023, 7:rkad030. 10.1093\/rap\/rkad030","journal-title":"Rheumatol Adv Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00063198-200209000-00019","article-title":"Sarcoidosis and other autoimmune disorders","volume":"8","author":"Sharma OP","year":"2002","unstructured":"Sharma OP. Sarcoidosis and other autoimmune disorders. Curr Opin Pulm Med. 2002, 8:452-6. 10.1097\/00063198-200209000-00019","journal-title":"Curr Opin Pulm Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001341","article-title":"A case report of sarcoidosis overlapped with Sjogren's syndrome","volume":"85","author":"Kudsi M","year":"2023","unstructured":"Kudsi M, Drie T, Khalayli N, Obaid Hassnah HA, Alghawe FA, Alhham L. A case report of sarcoidosis overlapped with Sjogren's syndrome. Ann Med Surg (Lond). 2023, 85:5752-5. 10.1097\/MS9.0000000000001341","journal-title":"Ann Med Surg (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000121237.98962.1e","article-title":"Sarcoidosis or Sj\u00f6gren syndrome? Clues to defining mimicry or coexistence in 59 cases","volume":"83","author":"Ramos-Casals M","year":"2004","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Garc\u00eda-Carrasco M, Font J. Sarcoidosis or Sj\u00f6gren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore). 2004, 83:85-95. 10.1097\/01.md.0000121237.98962.1e","journal-title":"Medicine (Baltimore)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3024-0","article-title":"Coexisting primary Sj\u00f6gren's syndrome and sarcoidosis: coincidence, mutually exclusive conditions or syndrome?","volume":"34","author":"Santiago T","year":"2014","unstructured":"Santiago T, Santiago M, Rovisco J, Ferreira J, Duarte C, Malcata A, Da Silva JA. Coexisting primary Sj\u00f6gren's syndrome and sarcoidosis: coincidence, mutually exclusive conditions or syndrome?. Rheumatol Int. 2014, 34:1619-22. 10.1007\/s00296-014-3024-0","journal-title":"Rheumatol Int"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13654","article-title":"Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan","volume":"44","author":"Wu CH","year":"2017","unstructured":"Wu CH, Chung PI, Wu CY, Chen YT, Chiu YW, Chang YT, Liu HN. Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan. J Dermatol. 2017, 44:423-30. 10.1111\/1346-8138.13654","journal-title":"J Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802220075","article-title":"Primary Sj\u00f6gren's syndrome and sarcoidosis: coexistence more than by chance?","volume":"37","author":"Hansen SR","year":"2008","unstructured":"Hansen SR, Hetta AK, Omdal R. Primary Sj\u00f6gren's syndrome and sarcoidosis: coexistence more than by chance?. Scand J Rheumatol. 2008, 37:485-6. 10.1080\/03009740802220075","journal-title":"Scand J Rheumatol"},{"key":"ref39","article-title":"Sarcoidosis and autoimmune thyroid disease. A case series of ten patients","volume":"24","author":"Isern V","year":"2007","unstructured":"Isern V, Lora-Tamayo J, Capdevila O, Villabona C, Ma\u00f1\u00e1 J. Sarcoidosis and autoimmune thyroid disease. A case series of ten patients. Sarcoidosis Vasc Diffuse Lung Dis. 2007, 24:148-52.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.1630976.x","article-title":"High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis","volume":"46","author":"Nakamura H","year":"1997","unstructured":"Nakamura H, Genma R, Mikami T, et al.. High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis. Clin Endocrinol (Oxf). 1997, 46:467-72. 10.1046\/j.1365-2265.1997.1630976.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00177","article-title":"Sarcoidosis and thyroid autoimmunity","volume":"8","author":"Fazzi P","year":"2017","unstructured":"Fazzi P, Fallahi P, Ferrari SM. Sarcoidosis and thyroid autoimmunity. Front Endocrinol (Lausanne). 2017, 8:177. 10.3389\/fendo.2017.00177","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/350285-current-epidemiological-and-clinical-features-of-sarcoidosis-in-japan-a-nationwide-claims-data-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:51:13Z","timestamp":1746186673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/350285-current-epidemiological-and-clinical-features-of-sarcoidosis-in-japan-a-nationwide-claims-data-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.83328","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}